|
1
|
Xu Y, Wang L, He J, Bi Y, Li M, Wang T,
Wang L, Jiang Y, Dai M, Lu J, et al: Prevalence and control of
diabetes in Chinese adults. JAMA. 310:948–959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yan P, Zhang Z, Wan Q, Zhu J, Li H, Gao C,
Ma H and Xu Y: Association of serum uric acid with bone mineral
density and clinical fractures in Chinese type 2 diabetes mellitus
patients: A cross-sectional study. Clin Chim Acta. 486:76–85. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen JS, Yang A and Murrell DF: Prevalence
and pathogenesis of osteopenia and osteoporosis in epidermolysis
bullosa: An evidence based review. Exp Dermatol. Aug 17–2018.(Epub
ahead of print). doi: 10.1111/exd.13771. View Article : Google Scholar
|
|
4
|
Schousboe JT: Vertebral fracture
identification as part of a comprehensive risk assessment in
patients with osteoporosis. Curr Osteoporos Rep. 16:573–583. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Crandall CJ: Risk assessment tools for
osteoporosis screening in postmenopausal women: A systematic
review. Curr Osteoporos Rep. 13:287–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eastell R, O'Neill TW, Hofbauer LC,
Langdahl B, Reid IR, Gold DT and Cummings SR: Postmenopausal
osteoporosis. Nat Rev Dis Primers. 2:160692016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baker ME and Lathe R: The promiscuous
estrogen receptor: Evolution of physiological estrogens and
response to phytochemicals and endocrine disruptors. J Steroid
Biochem Mol Biol. 184:29–37. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mathis KM, Sturgeon KM, Winkels RM,
Wiskemann J, De Souza MJ and Schmitz KH: Bone resorption and bone
metastasis risk. Med Hypotheses. 118:36–41. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang X, Lv Y, He P, Wang Z, Xiong F, He
L, Zheng X, Zhang D, Cao Q and Tang C: HDL impairs
osteoclastogenesis and induces osteoclast apoptosis via
upregulation of ABCG1 expression. Acta Biochim Biophys Sin
(Shanghai). 50:853–861. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Luo TB, Liu L and Cui ZQ: LncRNA
LINC00311 promotes the proliferation and differentiation of
osteoclasts in osteoporotic rats through the notch signaling
pathway by targeting DLL3. Cell Physiol Biochem. 47:2291–2306.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tantikanlayaporn D, Tourkova IL,
Larrouture Q, Luo J, Piyachaturawat P, Witt MR, Blair HC and
Robinson LJ: Sphingosine-1-phosphate modulates the effect of
estrogen in human osteoblasts. JBMR Plus. 2:217–226. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Valenti MT, Dalle Carbonare L and Mottes
M: Ectopic expression of the osteogenic master gene RUNX2 in
melanoma. World J Stem Cells. 10:78–81. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kanazawa I, Tanaka S and Sugimoto T: The
association between osteocalcin and chronic inflammation in
patients with type 2 diabetes mellitus. Calcif Tissue Int.
103:599–605. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu CC, Wang CC, Lu DH, Hsu LH, Yang KC and
Lin FH: Calcium phosphate cement delivering zoledronate decreases
bone turnover rate and restores bone architecture in ovariectomized
rats. Biomed Mater. 7:0350092012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tanaka S, Miyazaki T, Uemura Y, Kuroda T,
Miyakawa N, Nakamura T, Fukunaga M, Ohashi Y, Ohta H, Mori S, et
al: Design of a randomized clinical trial of concurrent treatment
with vitamin K2 and risedronate compared to risedronate alone in
osteoporotic patients: Japanese Osteoporosis Intervention Trial-03
(JOINT-03). J Bone Miner Metab. 32:298–304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin H, Wei B, Li G, Zheng J, Sun J, Chu J,
Zeng R and Niu Y: Sulforaphane reverses glucocorticoid-induced
apoptosis in osteoblastic cells through regulation of the Nrf2
pathway. Drug Des Devel Ther. 8:973–982. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vargas MR and Johnson JA: The Nrf2-ARE
cytoprotective pathway in astrocytes. Expert Rev Mol Med.
11:e172009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma Q: Role of nrf2 in oxidative stress and
toxicity. Annu Rev Pharmacol Toxicol. 53:401–426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong F, Wang S, Wang Y, Yang X, Jiang J,
Wu D, Qu X, Fan H and Yao R: Quercetin ameliorates learning and
memory via the Nrf2-ARE signaling pathway in d-galactose-induced
neurotoxicity in mice. Biochem Biophys Res Commun. 491:636–641.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shang ZZ, Li X, Sun HQ, Xiao GN, Wang CW
and Gong Q: Differentially expressed genes and signalling pathways
are involved in mouse osteoblast-like MC3T3-E1 cells exposed to
17-β estradiol. Int J Oral Sci. 6:142–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
You L, Gu W, Chen L, Pan L, Chen J and
Peng Y: MiR-378 overexpression attenuates high glucose-suppressed
osteogenic differentiation through targeting CASP3 and activating
PI3K/Akt signaling pathway. Int J Clin Exp Pathol. 7:7249–7261.
2014.PubMed/NCBI
|
|
23
|
Ralston SH and de Crombrugghe B: Genetic
regulation of bone mass and susceptibility to osteoporosis. Genes
Dev. 20:2492–2506. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hofbauer LC, Brueck CC, Singh SK and
Dobnig H: Osteoporosis in patients with diabetes mellitus. J Bone
Miner Res. 22:1317–1328. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng YZ, Yang SL, Wang JY, Ye M, Zhuo XY,
Wang LT, Chen H, Zhang H and Yang L: Irbesartan attenuates advanced
glycation end products-mediated damage in diabetes-associated
osteoporosis through the AGEs/RAGE pathway. Life Sci. 205:184–192.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mederle OA, Balas M, Ioanoviciu SD, Gurban
CV, Tudor A and Borza C: Correlations between bone turnover
markers, serum magnesium and bone mass density in postmenopausal
osteoporosis. Clin Interv Aging. 13:1383–1389. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Prior JC: Progesterone for the prevention
and treatment of osteoporosis in women. Climacteric. 21:366–374.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pardhe BD, Pathak S, Bhetwal A, Ghimire S,
Shakya S, Khanal PR and Marahatta SB: Effect of age and estrogen on
biochemical markers of bone turnover in postmenopausal women: A
population-based study from Nepal. Int J Womens Health. 9:781–788.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tian L, Yang R, Wei L, Liu J, Yang Y, Shao
F, Ma W, Li T, Wang Y and Guo T: Prevalence of osteoporosis and
related lifestyle and metabolic factors of postmenopausal women and
elderly men: A cross-sectional study in Gansu province,
Northwestern of China. Medicine (Baltimore). 96:e82942017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gopalakrishnan V, Vignesh RC, Arunakaran
J, Aruldhas MM and Srinivasan N: Effects of glucose and its
modulation by insulin and estradiol on BMSC differentiation into
osteoblastic lineages. Biochem Cell Biol. 84:93–101. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He HL, Liu C, Li BX, Wang CQ, Li HT and Gu
L: Estrogen-induced Tgfbr1 and Bmpr1a expression
repressed via estrogen receptor beta in MC3T3-E1 cells. Chin Med J
(Engl). 131:2558–2565. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fan S, Gao X, Chen P and Li X: Myricetin
ameliorates glucocorticoid-induced osteoporosis through the ERK
signaling pathway. Life Sci. 207:205–211. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Uskoković V, Graziani V, Wu VM, Fadeeva
IV, Fomin AS, Presniakov IA, Fosca M, Ortenzi M, Caminiti R and Rau
JV: Gold is for the mistress, silver for the maid: Enhanced
mechanical properties, osteoinduction and antibacterial activity
due to iron doping of tricalcium phosphate bone cements. Mater Sci
Eng C Mater Biol Appl. 94:798–810. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kook SH, Kim KA, Ji H, Lee D and Lee JC:
Irradiation inhibits the maturation and mineralization of
osteoblasts via the activation of Nrf2/HO-1 pathway. Mol Cell
Biochem. 410:255–266. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zwerina J, Tzima S, Hayer S, Redlich K,
Hoffmann O, Hanslik-Schnabel B, Smolen JS, Kollias G and Schett G:
Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone
resorption. FASEB J. 19:2011–2013. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kook YA, Lee SK, Son DH, Kim Y, Kang KH,
Cho JH, Kim SC, Kim YS, Lee HJ, Lee SK and Kim EC: Effects of
substance P on osteoblastic differentiation and heme oxygenase-1 in
human periodontal ligament cells. Cell Biol Int. 33:424–428. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Choi EM, Suh KS, Kim YJ, Hong SM, Park SY
and Chon S: Glabridin alleviates the toxic effects of methylglyoxal
on osteoblastic MC3T3-E1 cells by increasing expression of the
glyoxalase system and Nrf2/HO-1 signaling and protecting
mitochondrial function. J Agric Food Chem. 64:226–235. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han D, Gao J, Gu X, Hengstler JG, Zhang L,
Shahid M, Ali T and Han B: P21Waf1/Cip1 depletion
promotes dexamethasone-induced apoptosis in osteoblastic MC3T3-E1
cells by inhibiting the Nrf2/HO-1 pathway. Arch Toxicol.
92:679–692. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tekula S, Khurana A, Anchi P and Godugu C:
Withaferin-A attenuates multiple low doses of Streptozotocin
(MLD-STZ) induced type 1 diabetes. Biomed Pharmacother.
106:1428–1440. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ghiasi SM, Dahllof MS, Osmai Y, Osmai M,
Jakobsen KK, Aivazidis A, Tyrberg B, Perruzza L, Prause MCB,
Christensen DP, et al: Regulation of the β-cell inflammasome and
contribution to stress-induced cellular dysfunction and apoptosis.
Mol Cell Endocrinol. 478:106–114. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zheng G, Li H, Zhang T, Yang L, Yao S,
Chen S, Zheng M, Zhao Q and Tian H: Irisin protects macrophages
from oxidized low density lipoprotein-induced apoptosis by
inhibiting the endoplasmic reticulum stress pathway. Saudi J Biol
Sci. 25:849–857. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhao W, Zhang WL, Yang B, Sun J and Yang
MW: NIPA2 regulates osteoblast function via its effect on apoptosis
pathways in type 2 diabetes osteoporosis. Biochem Biophys Res
Commun. 513:883–890. 2019. View Article : Google Scholar : PubMed/NCBI
|
